RxSight, Inc. Ttl Fee Amt
RxSight, Inc. (RXST) had Ttl Fee Amt of $2.37 thousand as of 2026-08-07, per its SC TO-I filed 2026-08-10.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-08-10
- 2026-08-07: Ttl Fee Amt $2.37K.
- 2026-07-22: Ttl Fee Amt $2.61K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-08-07 | $2.37K SC TO-I · filed 2026-08-10 |
| 2026-07-22 | $2.61K S-8 · filed 2026-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |